Buck Kristen K 4
4 · LISATA THERAPEUTICS, INC. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Buck Kristen K
EVP, R&D and CMO
Transactions
- Award
Common Stock
2024-10-01$2.93/sh+15,000$43,950→ 69,035 total - Tax Payment
Common Stock
2024-10-01$2.93/sh−6,363$18,644→ 62,672 total
Footnotes (3)
- [F1]Reflects 15,000 in performance-based stock units, the criteria for which was satisfied on October 1, 2024, and which vested in full on that same day.
- [F2]Includes 30,325 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of performance-based stock units.